These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vaccination against drug resistance in HIV infection. Boberg A; Isaguliants M Expert Rev Vaccines; 2008 Feb; 7(1):131-45. PubMed ID: 18251699 [TBL] [Abstract][Full Text] [Related]
4. Rethinking globally relevant vaccine strategies to human immunodeficiency virus type-1. Gray CM; Puren AJ Arch Immunol Ther Exp (Warsz); 2000; 48(4):235-41. PubMed ID: 11059639 [TBL] [Abstract][Full Text] [Related]
5. A review of vaccine research and development: the human immunodeficiency virus (HIV). Girard MP; Osmanov SK; Kieny MP Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy and therapeutic vaccines in HIV infection. García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008 [TBL] [Abstract][Full Text] [Related]
7. Progress and obstacles in the development of an AIDS vaccine. Letvin NL Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514 [TBL] [Abstract][Full Text] [Related]
8. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever? Egan MA Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741 [No Abstract] [Full Text] [Related]
9. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. Blower S; Schwartz EJ; Mills J AIDS Rev; 2003; 5(2):113-25. PubMed ID: 12876900 [TBL] [Abstract][Full Text] [Related]
10. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV. White A Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264 [TBL] [Abstract][Full Text] [Related]
11. [Design, development and successful application of safe and effective HIV therapeutic and prophylactic vaccines]. Abalaka JO Zhonghua Nan Ke Xue; 2005 Jan; 11(1):8-16. PubMed ID: 15704674 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of primate models for AIDS. Haigwood NL AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic immunization strategies for the control of HIV-1. Dorrell L Expert Rev Vaccines; 2005 Aug; 4(4):513-20. PubMed ID: 16117708 [TBL] [Abstract][Full Text] [Related]
14. [Various approaches of therapeutic vaccination for the treatment of HIV type 1 infection]. Lazrek M; Lobert PE; Goffard A; Schanen C; Dewilde A; Bocket L; Hober D Ann Biol Clin (Paris); 2005; 63(6):581-8. PubMed ID: 16330376 [TBL] [Abstract][Full Text] [Related]
15. Salk's HIV immunogen: an immune-based therapy in human trials since 1988. Crit Path AIDS Proj; 1994-1995 Winter; (No 30):1, 20-3. PubMed ID: 11362152 [TBL] [Abstract][Full Text] [Related]
16. Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection. Jones T Curr Opin Investig Drugs; 2010 Aug; 11(8):964-70. PubMed ID: 20721838 [TBL] [Abstract][Full Text] [Related]
17. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. Betts MR; Gray CM; Cox JH; Ferrari G Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631 [TBL] [Abstract][Full Text] [Related]
18. New strategies to combat HIV: augmenting antiviral immunity. Smith KA; Boyle BA AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321 [No Abstract] [Full Text] [Related]
19. Honing the immune attack on HIV. Gilden D GMHC Treat Issues; 1996 Dec; 10(12):8-11. PubMed ID: 11364019 [TBL] [Abstract][Full Text] [Related]
20. [Vaccines against HIV]. Holm-Hansen C Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]